tiprankstipranks
Trending News
More News >
Kumiai Chemical Industry Co., Ltd. (JP:4996)
:4996
Japanese Market

Kumiai Chemical Industry Co., Ltd. (4996) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4996

Kumiai Chemical Industry Co., Ltd.

(4996)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 4o)
Rating:64Neutral
Price Target:
¥742.00
▲(4.51% Upside)
Kumiai Chemical Industry Co., Ltd. has a solid financial foundation with steady revenue growth and operational efficiency. However, profitability margins and rising debt levels are concerns. The technical analysis indicates a bearish trend, but the stock's valuation is reasonable with an attractive dividend yield. These factors combine to give a moderate overall stock score.
Positive Factors
Steady Revenue Growth
Consistent revenue growth indicates strong market demand and effective sales strategies, supporting long-term business sustainability.
Operational Efficiency
Efficient operations help maintain profitability and competitiveness, ensuring the company can withstand market fluctuations.
Strong Capital Structure
A strong capital structure provides financial stability and flexibility, enabling strategic investments and growth opportunities.
Negative Factors
Rising Debt Levels
Rising debt levels can strain financial resources and limit the company's ability to invest in growth or weather economic downturns.
Declining Profit Margins
Decreasing profit margins may indicate cost pressures or pricing challenges, potentially impacting long-term financial health.
Volatile Free Cash Flow
Volatile free cash flow can affect the company's ability to fund operations and growth initiatives, posing risks to financial stability.

Kumiai Chemical Industry Co., Ltd. (4996) vs. iShares MSCI Japan ETF (EWJ)

Kumiai Chemical Industry Co., Ltd. Business Overview & Revenue Model

Company DescriptionKumiai Chemical Industry Co., Ltd. (4996) is a leading Japanese manufacturer specializing in agrochemicals, pharmaceuticals, and specialty chemicals. Established in 1948, the company operates primarily in the agricultural sector, providing innovative crop protection solutions, including pesticides and herbicides, aimed at enhancing agricultural productivity. Additionally, Kumiai Chemical is involved in the production of chemical intermediates and fine chemicals for various industrial applications. The company is committed to sustainability and invests in research and development to create environmentally friendly products that meet the evolving needs of its customers.
How the Company Makes MoneyKumiai Chemical Industry Co., Ltd. generates revenue primarily through the sale of its agrochemical products, including pesticides, herbicides, and fungicides, which are essential for modern agriculture. The company also earns income from its pharmaceutical and specialty chemical divisions, which cater to various sectors, including healthcare and manufacturing. Key revenue streams include direct sales to agricultural producers, distribution partnerships, and licensing agreements for its proprietary technologies. Significant partnerships with agricultural cooperatives and distribution channels further enhance its market reach, while ongoing investments in R&D enable the company to innovate and meet regulatory standards, thereby maintaining competitive pricing and attracting a broader customer base.

Kumiai Chemical Industry Co., Ltd. Financial Statement Overview

Summary
Kumiai Chemical Industry Co., Ltd. shows strong revenue growth and operational efficiency. However, recent declines in profitability and negative cash flows are concerning. The company maintains a strong equity base, but increasing debt levels and cash flow issues suggest a need for careful financial management.
Income Statement
72
Positive
Kumiai Chemical Industry Co., Ltd. has shown consistent revenue growth over the years, with a notable increase from 2019 to 2024. The gross profit margin has been stable, reflecting effective cost management. However, the recent decline in net income and EBIT margins indicates pressure on profitability. EBITDA margins remain healthy, suggesting good operational efficiency.
Balance Sheet
68
Positive
The company maintains a strong equity base, with a stable debt-to-equity ratio that reflects controlled leverage. The equity ratio is solid, indicating financial stability. However, the increase in total debt over the years could pose a risk if not managed effectively. Return on equity has been strong, although it has shown some recent decline.
Cash Flow
60
Neutral
Cash flow analysis reveals challenges, particularly with negative operating and free cash flows in the latest year. The operating cash flow to net income ratio is negative, indicating inefficiencies in turning income into cash. Historical free cash flow fluctuations highlight potential liquidity risks.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue166.33B170.46B161.05B161.00B145.30B118.18B
Gross Profit33.44B34.37B35.38B36.66B34.20B29.04B
EBITDA13.46B16.06B23.32B28.63B28.14B16.88B
Net Income9.81B4.38B13.59B18.02B16.33B9.02B
Balance Sheet
Total Assets267.31B248.21B275.47B226.94B204.60B169.17B
Cash, Cash Equivalents and Short-Term Investments29.09B21.98B27.40B27.08B22.30B20.05B
Total Debt67.16B51.11B74.26B45.76B34.93B22.39B
Total Liabilities111.34B97.10B122.53B87.09B82.61B59.22B
Stockholders Equity148.81B144.49B145.92B133.02B115.47B103.89B
Cash Flow
Free Cash Flow0.0025.53B-25.91B-4.06B-9.14B-2.46B
Operating Cash Flow0.0033.80B-16.73B4.76B-1.16B4.48B
Investing Cash Flow0.00-8.93B-8.76B-10.10B-7.82B-5.31B
Financing Cash Flow0.00-27.85B23.61B6.86B5.62B439.00M

Kumiai Chemical Industry Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price710.00
Price Trends
50DMA
692.45
Positive
100DMA
754.58
Negative
200DMA
764.99
Negative
Market Momentum
MACD
0.49
Negative
RSI
58.25
Neutral
STOCH
86.32
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4996, the sentiment is Positive. The current price of 710 is above the 20-day moving average (MA) of 691.50, above the 50-day MA of 692.45, and below the 200-day MA of 764.99, indicating a neutral trend. The MACD of 0.49 indicates Negative momentum. The RSI at 58.25 is Neutral, neither overbought nor oversold. The STOCH value of 86.32 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4996.

Kumiai Chemical Industry Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥23.98B9.633.82%8.02%42.17%
74
Outperform
¥203.81B12.974.09%1.69%0.94%
74
Outperform
¥110.03B7.904.15%1.16%167.89%
72
Outperform
¥39.55B9.582.86%4.66%19.39%
69
Neutral
¥79.83B15.562.35%6.95%8.85%
64
Neutral
¥87.95B19.323.41%5.84%-67.78%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4996
Kumiai Chemical Industry Co., Ltd.
709.00
-25.35
-3.45%
JP:4028
ISHIHARA SANGYO KAISHA, LTD.
2,746.00
1,289.03
88.47%
JP:4041
Nippon Soda Co., Ltd.
3,640.00
856.46
30.77%
JP:4979
OAT Agrio Co., Ltd.
2,220.00
308.26
16.12%
JP:4992
Hokko Chemical Industry Co., Ltd.
1,616.00
341.72
26.82%
JP:4997
Nihon Nohyaku Co., Ltd.
1,017.00
336.11
49.36%

Kumiai Chemical Industry Co., Ltd. Corporate Events

Kumiai Chemical Reports Increased Sales but Declining Profits
Jun 6, 2025

Kumiai Chemical Industry Co., Ltd. reported its consolidated financial results for the six months ending April 30, 2025, showing a 9.2% increase in net sales compared to the previous year. However, the company experienced a significant decline in ordinary profit and profit attributable to owners of the parent, with decreases of 36.2% and 32.7% respectively, indicating challenges in profitability despite increased sales.

Kumiai Chemical Revises Q2 Earnings Forecast Amid Strong Overseas Sales
Jun 3, 2025

Kumiai Chemical Industry Co., Ltd. has revised its earnings forecast for the second quarter of the fiscal year ending October 31, 2025, due to increased net sales driven by advanced shipments to overseas markets in its agricultural chemicals and agriculture-related business. While operating income is expected to rise significantly, ordinary and net income remain largely unchanged due to foreign exchange losses from the yen’s appreciation. The full-year earnings forecast remains unchanged, with potential revisions to be disclosed if necessary.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025